Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
We target 99% or higher purity
Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Cardiovasc Diabetol 13:153 Ma GF, Chen S, Yin L, Gao XD, Yao WB (2014) Exendin-4 ameliorates oxidized-LDL-induced Inhibition of macrophage migration in vitro via the NF-kappaB pathway
Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells
US$ 28.45
US$ 21.68
US$ 26.23
US$ 21.15
US$ 29.82
US$ 29.50
US$ 23.53
